bpc 157 type 1 diabetes BPC-157 Injectable Peptide for Healing & Recovery BPC-157 Delayed Pro | Fullscript

Since then, several clinical studies have shown its safe and effective use - but the pharmacuetical companies have decided not to (yet) pursue FDA-Approval (likely because each new FDA-Approval costs several million dollars to go through the process, and because there are a good deal of drugs used off-label in the way tranexamic acid is for melasma, especially when the drug has a long history of safety and efficacy, as is in this case)

Cardiac protection: Unlike BPC-157's gastric origins, TB-500 has been studied particularly for cardiac applications, showing potential for heart tissue repair

Appetite changes often occur early in treatment

Set up your station